-
公开(公告)号:US5428033A
公开(公告)日:1995-06-27
申请号:US774396
申请日:1991-10-10
申请人: Michel L. Belley , Serge Leger , Patrick Roy , Yi B. Xiang , Marc Labelle
发明人: Michel L. Belley , Serge Leger , Patrick Roy , Yi B. Xiang , Marc Labelle
IPC分类号: A61K31/47 , A61K45/06 , A61P11/00 , A61P27/02 , A61P27/14 , A61P27/16 , A61P29/00 , A61P37/08 , A61P43/00 , C07D215/12 , C07D215/14 , C07D215/18 , C07D215/38 , C07D215/48 , C07D401/10 , C07D405/10 , C07D409/10 , A61K31/54
CPC分类号: C07D215/18 , C07D215/12
摘要: Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
摘要翻译: 具有式I的化合物:I是白三烯拮抗剂和白三烯生物合成的抑制剂。 这些化合物可用作抗哮喘,抗过敏,抗炎和细胞保护剂。 它们也可用于治疗心绞痛,脑痉挛,肾小球肾炎,肝炎,内毒素血症,葡萄膜炎和同种异体移植排斥。
-
公开(公告)号:US5565473A
公开(公告)日:1996-10-15
申请号:US392592
申请日:1995-02-23
申请人: Michel L. Belley , Serge Leger , Marc Labelle , Patrick Roy , Yi B. Xiang , Daniel Guay
发明人: Michel L. Belley , Serge Leger , Marc Labelle , Patrick Roy , Yi B. Xiang , Daniel Guay
IPC分类号: C07D215/12 , C07D215/18 , A01N43/42 , C07D215/36
CPC分类号: C07D215/18 , C07D215/12 , Y10S514/826 , Y10S514/924
摘要: Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
-
3.
公开(公告)号:US5856322A
公开(公告)日:1999-01-05
申请号:US598758
申请日:1996-02-08
申请人: Michel L. Belley , Serge Leger , Patrick Roy , Marc Labelle , Yi Bin Xiang , Daniel Guay
发明人: Michel L. Belley , Serge Leger , Patrick Roy , Marc Labelle , Yi Bin Xiang , Daniel Guay
IPC分类号: C07D215/12 , C07D215/18 , A61K31/54 , A01N43/42 , A01N43/54 , A01N43/58
CPC分类号: C07D215/18 , C07D215/12
摘要: Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
摘要翻译: 具有式I的化合物:I是白三烯拮抗剂和白三烯生物合成的抑制剂。 这些化合物可用作抗哮喘,抗过敏,抗炎和细胞保护剂。 它们也可用于治疗心绞痛,脑痉挛,肾小球肾炎,肝炎,内毒素血症,葡萄膜炎和同种异体移植排斥。
-
公开(公告)号:US5266568A
公开(公告)日:1993-11-30
申请号:US774403
申请日:1991-10-10
申请人: Michel L. Belley , Yves LeBlanc , Marc Labelle
发明人: Michel L. Belley , Yves LeBlanc , Marc Labelle
IPC分类号: C07D215/14 , C07D215/18 , A61K31/54 , A61K31/47 , C07D215/12
CPC分类号: C07D215/14 , C07D215/18
摘要: Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
摘要翻译: 具有式I的化合物:I是白三烯拮抗剂和白三烯生物合成的抑制剂。 这些化合物可用作抗哮喘,抗过敏,抗炎和细胞保护剂。 它们也可用于治疗心绞痛,脑痉挛,肾小球肾炎,肝炎,内毒素血症,葡萄膜炎和同种异体移植排斥。
-
5.
公开(公告)号:US5472964A
公开(公告)日:1995-12-05
申请号:US260592
申请日:1994-06-16
申请人: Robert N. Young , Marc Labelle , Yves Leblanc , Yi B. Xiang , Cheuk K. Lau , Claude Dufresne , Yves Gareau
发明人: Robert N. Young , Marc Labelle , Yves Leblanc , Yi B. Xiang , Cheuk K. Lau , Claude Dufresne , Yves Gareau
IPC分类号: C07D513/04 , A61K31/44 , A61K45/06 , A61P11/06 , A61P27/02 , A61P29/00 , A61P37/08 , A61P43/00 , C07D491/04 , C07D491/048 , C07D495/04 , A61K31/435
CPC分类号: C07D491/04 , C07D495/04 , C07D513/04
摘要: Compounds having the formula I: ##STR1## are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
摘要翻译: 具有式I的化合物:I是白三烯的作用的拮抗剂。 这些化合物可用作抗哮喘,抗过敏,抗炎和细胞保护剂。 它们也可用于治疗心绞痛,脑痉挛,肾小球肾炎,肝炎,内毒素血症,葡萄膜炎和同种异体移植排斥。
-
公开(公告)号:US20170369444A1
公开(公告)日:2017-12-28
申请号:US15129351
申请日:2015-03-30
发明人: Marc Labelle , Rui Zhang , Cuthbert D. Martyr , Neerja Saraswat , Thomas Boesen
IPC分类号: C07D213/79 , C07D471/04 , C07D417/12 , C07D405/12 , C07D237/24 , C07D401/12 , C07D401/06 , C07D239/28 , C07D487/04 , C07D409/12
CPC分类号: C07D213/79 , A61K31/44 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/4985 , A61K45/06 , C07D213/38 , C07D213/48 , C07D213/56 , C07D237/24 , C07D239/28 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/04 , C07D417/12 , C07D471/04 , C07D487/04 , A61K2300/00
摘要: Compounds of the form in which Q is selected from —COOH—CH═NR12, —W, —CH2NHR13, —CH=0 and —CH(OR17)2 capable of modulating the activity of histone demethylases (HDMEs), which are useful for prevention and/or treatment of diseases in which genomic dysregulation is involved in the pathogenesis, such as e.g. cancer and formulations and methods of use of such compounds.
-
公开(公告)号:US08426358B2
公开(公告)日:2013-04-23
申请号:US13087261
申请日:2011-04-14
申请人: Frank Kayser , Marc Labelle , Bei Shan , Jian Zhang , Mingyue Zhou
发明人: Frank Kayser , Marc Labelle , Bei Shan , Jian Zhang , Mingyue Zhou
CPC分类号: C12N9/1029 , A61K31/497 , A61K38/45 , C07D403/12 , C07D417/12
摘要: The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, inflammation, thrombosis and other conditions and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
摘要翻译: 本发明提供了通过改变LCAT多肽来治疗动脉粥样硬化,炎症,血栓形成和其它病症并降低或预防受试者胆固醇积聚的化合物,药物组合物和方法。
-
公开(公告)号:US20050043330A1
公开(公告)日:2005-02-24
申请号:US10928784
申请日:2004-08-26
申请人: Michelle Browner , David Clark , Timothy Cushing , Xiaolin Hao , Ronald Hawley , Xiao He , Juan Jaen , Sharada Labadie , Marie-Louise Smith , Francisco Talamas , Nigel Walker , Marc Labelle
发明人: Michelle Browner , David Clark , Timothy Cushing , Xiaolin Hao , Ronald Hawley , Xiao He , Juan Jaen , Sharada Labadie , Marie-Louise Smith , Francisco Talamas , Nigel Walker , Marc Labelle
IPC分类号: A61K31/4709 , A61K31/4745 , A61K31/5377 , A61P3/10 , A61P17/06 , A61P19/02 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D413/14 , C07D417/04 , C07D471/04 , C12N15/25 , C12N15/28 , A61K31/519 , A61K31/517 , C07D487/02 , C07D43/02
CPC分类号: C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D417/04 , C07D471/04
摘要: Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain fused carbocyclic or heterocyclic rings.
-
公开(公告)号:US07244727B2
公开(公告)日:2007-07-17
申请号:US10720844
申请日:2003-11-21
申请人: Brian M. Fox , Noboru Furukawa , Xiaolin Hao , Kiyosei Iio , Takashi Inaba , Simon M. Jackson , Frank Kayser , Marc Labelle , Kexue Li , Takuya Matsui , Dustin L. McMinn , Nobuya Ogawa , Steven M. Rubenstein , Shoichi Sagawa , Kazuyuki Sugimoto , Masahiro Suzuki , Masahiro Tanaka , Guosen Ye , Atsuhito Yoshida , Jian Zhang
发明人: Brian M. Fox , Noboru Furukawa , Xiaolin Hao , Kiyosei Iio , Takashi Inaba , Simon M. Jackson , Frank Kayser , Marc Labelle , Kexue Li , Takuya Matsui , Dustin L. McMinn , Nobuya Ogawa , Steven M. Rubenstein , Shoichi Sagawa , Kazuyuki Sugimoto , Masahiro Suzuki , Masahiro Tanaka , Guosen Ye , Atsuhito Yoshida , Jian Zhang
IPC分类号: C07D498/04 , A61K31/542 , A61P3/04 , A61P3/08 , C07D491/04 , C07D495/04 , A61K31/538 , A61K31/519
CPC分类号: C07D491/04
摘要: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.
摘要翻译: 本文提供了可用于治疗或预防代谢和细胞增殖性疾病或病症的化合物,药物组合物和方法。 特别地,本发明提供调节参与脂质代谢和细胞增殖的蛋白质的活性的化合物。
-
公开(公告)号:US07176314B2
公开(公告)日:2007-02-13
申请号:US10314428
申请日:2002-12-04
申请人: Timothy D. Cushing , Xiao He , Marie-Louise Smith , Michael R. DeGraffenreid , Jay Powers , Craig S. Tomooka , David L. Clark , Xiaolin Hao , Juan C. Jaen , Marc Labelle , Nigel P. C. Walker , Adrian L. Gill , Francisco X. Talamas , Sharada Labadie
发明人: Timothy D. Cushing , Xiao He , Marie-Louise Smith , Michael R. DeGraffenreid , Jay Powers , Craig S. Tomooka , David L. Clark , Xiaolin Hao , Juan C. Jaen , Marc Labelle , Nigel P. C. Walker , Adrian L. Gill , Francisco X. Talamas , Sharada Labadie
IPC分类号: C07D215/00 , C09B25/00
CPC分类号: C07D401/04 , A61K31/4709 , C07D401/14 , C07D405/14 , A61K2300/00
摘要: Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain quinoline or quinazoline rings.
摘要翻译: 本文提供了可用于治疗炎症,免疫调节,代谢和细胞增殖性病症或疾病的化合物,组合物和方法。 特别地,本发明提供调节参与炎症,代谢和细胞增殖的蛋白质的表达和/或功能的化合物。 主题化合物含有喹啉或喹唑啉环。
-
-
-
-
-
-
-
-
-